Back to search
FDAFDA · Food and drugs·Recall number D-0080-2018

Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40

Published November 22, 2017 · Recall initiated: October 13, 2017

Summary

FDA records drug Class II recall D-0080-2018, published November 22, 2017 and initiated October 13, 2017. Recalling firm: PharMEDium Services, LLC.; Status: Terminated; Reported quantity: 499 syringes; Lot: Lot#: 172820134M, Exp 01/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent drug: out of specification result for potency

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
PharMEDium Services, LLC.
Distributor
CA, IL
Lot
Lot#: 172820134M, Exp 01/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40 recalled?

Yes. FDA published recall D-0080-2018 on November 22, 2017. Reported hazard: Superpotent drug: out of specification result for potency

What should I do if I have this product?

Voluntary: Firm initiated · Telephone